
Goldman Sachs Identifies 23 Defensive Stocks for Volatility Protection
Goldman Sachs strategist Ben Snider has identified 23 Russell 1000 stocks in the health care and consumer staples sectors that offer defensive characteristics alongside quality-growth potential. These selections are intended for investors concerned about a deteriorating growth outlook, focusing on companies with low volatility and high free-cash-flow yields. The list includes major names such as Abbott Laboratories, CVS Health, and Merck, aiming to provide stability amidst market uncertainty.

